Catequentinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Catequentinib, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) [Phase 3]